Unique ID issued by UMIN | UMIN000028641 |
---|---|
Receipt number | R000032781 |
Scientific Title | Role of gastric mucosal barrier dysfunction during gastric carcinogenesis after H.pylori eradication |
Date of disclosure of the study information | 2017/09/22 |
Last modified on | 2024/02/15 09:27:20 |
Role of gastric mucosal barrier dysfunction during gastric carcinogenesis after H.pylori eradication
Mucosal barrier dysfunction during gastric carcinogenesis after H.pylori eradication
Role of gastric mucosal barrier dysfunction during gastric carcinogenesis after H.pylori eradication
Mucosal barrier dysfunction during gastric carcinogenesis after H.pylori eradication
Japan |
gastric cancer after successful eradication
Gastroenterology |
Malignancy
NO
To clarify mucosal barrier damage due to factors of gastric juice after eradication
Others
To clarify difference in mucosal barrier dysfunction caused by acetaldehyde or paptideglycan
Difference in mucosal barrier dysfunction caused by acetaldehyde or peptideglycan
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Treatment
Device,equipment |
endoscopic biopsy
20 | years-old | < |
85 | years-old | > |
Male and Female
patients with follow-up endoscopic examination after ESD for post-eradication gastric cancer
1. contraindication for endoscoic biopsy
2. patients who take NSAIDs, steroid, or immunosuppressive medication
3. patients treated by surgecy for upper GI tract
4. patients who take antibiotics in 12 months
5. pregnancy
6. severe general condition or phycological dysorder
7. inappropriate for enrolling this trial
40
1st name | Kaname |
Middle name | |
Last name | Uno |
Tohoku university
Gastroenterology
981-8574
1-1 Seiryo-cho Aoba-ku Sendai, Miyagi, Japan
022-717-7171
kaname-1@umin.ac.jp
1st name | Kaname |
Middle name | |
Last name | Uno |
Tohoku university
Gastroenterology
981-8574
1-1 Seiryo-cho, aobaku, Sendai, Miyagi, Japan
022-717-7171
kaname-1@umin.ac.jp
Tohoku university
Tohoku univerisity
Self funding
Tohoku University Hospital IRB
1-1 Seiryo-cho Aoba-ku Sendai Miyagi
022-728-4105
office@nrs.hosp.tohoku.ac.jp
NO
2017 | Year | 09 | Month | 22 | Day |
https://pubmed.ncbi.nlm.nih.gov/37943385/
Partially published
https://pubmed.ncbi.nlm.nih.gov/37943385/
40
Methods: To evaluate barrier function of background mucosa against the stimulations, we applied biopsy samples from 76 patients on mini-Ussing chamber system and immunohistochemical study.
Results: In the UCs, Pg. lipopolysaccharide reduced the impedance of metaplastic and inflamed mucosa with increases in mRNA expression of toll-like receptor 2, tumor necrosis factor, and apoptotic markers.
2024 | Year | 02 | Month | 15 | Day |
Forty patients with GC detected at least 2 years after successful H. pylori eradication therapy (post-eradication GC), who visited our department between June 2019 and November 2020, were enrolled in this study.
Under endoscopic inspection, three biopsy samples were obtained from background mucosa suffering from GC, and they were separately applied to histological studies, a mini-Ussing chamber system (mUCs), and molecular biological studies.
none
biopsy samples to mUCs to evaluate changes in the mucosal barrier function by external stimulations
The degree of inflammation, activity, atrophy, and metaplasia of endoscopic biopsy specimens was evaluated based on the uSS
Main results already published
2017 | Year | 08 | Month | 11 | Day |
2017 | Year | 09 | Month | 22 | Day |
2017 | Year | 10 | Month | 01 | Day |
2022 | Year | 09 | Month | 30 | Day |
2017 | Year | 08 | Month | 11 | Day |
2024 | Year | 02 | Month | 15 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000032781